These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 11607817)

  • 21. Duplication and triplication of der(21)t(8;21)(q22;q22) in acute myeloid leukemia.
    Mikulasovich M; LeBlanc A; Scalise A; Manwani D; Keyzner A; Najfeld V
    Cancer Genet Cytogenet; 2009 Jan; 188(2):83-7. PubMed ID: 19100510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discrimination of target by siRNA: designing of AML1-MTG8 fusion mRNA-specific siRNA sequences.
    Kasashima K; Sakota E; Kozu T
    Biochimie; 2004; 86(9-10):713-21. PubMed ID: 15556282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene.
    Yergeau DA; Hetherington CJ; Wang Q; Zhang P; Sharpe AH; Binder M; Marín-Padilla M; Tenen DG; Speck NA; Zhang DE
    Nat Genet; 1997 Mar; 15(3):303-6. PubMed ID: 9054947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukemogenic AML1-ETO fusion protein upregulates expression of connexin 43: the role in AML 1-ETO-induced growth arrest in leukemic cells.
    Li X; Xu YB; Wang Q; Lu Y; Zheng Y; Wang YC; Lübbert M; Zhao KW; Chen GQ
    J Cell Physiol; 2006 Sep; 208(3):594-601. PubMed ID: 16741927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NHR4 domain mutations of ETO are probably very infrequent in AML1-ETO positive myeloid leukemia cells.
    Hackanson B; Abdelkarim M; Jansen JH; Lübbert M
    Leukemia; 2010 Apr; 24(4):860-1. PubMed ID: 20090777
    [No Abstract]   [Full Text] [Related]  

  • 26. AML1 and Pebp2: the gene for a transcription factor is involved in recurring translocations in human acute myeloid leukemia.
    Rowley JD
    Jpn J Cancer Res; 1994 Dec; 85(12):inside front cover. PubMed ID: 7852178
    [No Abstract]   [Full Text] [Related]  

  • 27. Cryptic chromosomal aberrations leading to an AML1/ETO rearrangement are frequently caused by small insertions.
    Gamerdinger U; Teigler-Schlegel A; Pils S; Bruch J; Viehmann S; Keller M; Jauch A; Harbott J
    Genes Chromosomes Cancer; 2003 Mar; 36(3):261-72. PubMed ID: 12557226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transformation properties of the ETO gene, fusion partner in t(8:21) leukemias.
    Wang J; Wang M; Liu JM
    Cancer Res; 1997 Jul; 57(14):2951-5. PubMed ID: 9230207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.
    Wang YY; Zhou GB; Yin T; Chen B; Shi JY; Liang WX; Jin XL; You JH; Yang G; Shen ZX; Chen J; Xiong SM; Chen GQ; Xu F; Liu YW; Chen Z; Chen SJ
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1104-9. PubMed ID: 15650049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO.
    Fliegauf M; Stock M; Berg T; Lübbert M
    Oncogene; 2004 Dec; 23(56):9070-81. PubMed ID: 15489901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ribozymes cleave the AML1/MTG8 fusion transcript and inhibit proliferation of leukemic cells with t(8;21).
    Matsushita H; Kobayashi H; Mori S; Kizaki M; Ikeda Y
    Biochem Biophys Res Commun; 1995 Oct; 215(2):431-7. PubMed ID: 7487974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complex translocation (8;12;21): a new variant of t(8;21) in acute myeloid leukemia.
    Farra C; Awwad J; Valent A; Lozach F; Bernheim A
    Cancer Genet Cytogenet; 2004 Dec; 155(2):138-42. PubMed ID: 15571799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute myeloid leukemia (AML) with t(8;21)(q22;q22) relapsing as AML with t(3;21)(q26;q22).
    Bacher U; Schnittger S; Kern W; Trenn G; Weisser M; Haferlach T; Schoch C
    Cancer Genet Cytogenet; 2006 Jul; 168(2):172-4. PubMed ID: 16843110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular cytogenetic findings in a three-way novel variant of t(1;8;21)(p35;q22;q22): a unique relocation of the AML1/ETO fusion gene 1p35 in AML-M2.
    Ahmad F; Kokate P; Chheda P; Dalvi R; Das BR; Mandava S
    Cancer Genet Cytogenet; 2008 Jan; 180(2):153-7. PubMed ID: 18206543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of ETV6/MDS1/Evi-1 chimeric transcripts in a patient with acute myelocytic leukemia and t(3;12)(q26;p13).
    Nishimura Y; Wada H; Mori A; Takatsuka H; Tamura A; Fujimori Y; Okamoto T; Takemoto Y; Kakishita E
    Int J Hematol; 2000 Jul; 72(1):108-9. PubMed ID: 10979219
    [No Abstract]   [Full Text] [Related]  

  • 36. Fusion of AML1/Runx1 to copine VIII, a novel member of the copine family, in an aggressive acute myelogenous leukemia with t(12;21) translocation.
    Ramsey H; Zhang DE; Richkind K; Burcoglu-O'Ral A; Hromas R
    Leukemia; 2003 Aug; 17(8):1665-6. PubMed ID: 12886257
    [No Abstract]   [Full Text] [Related]  

  • 37. AML1-ETO positive AML: first report from India.
    Dutta P; Hasan SK; Sazawal S; Kumar B; Bhattacharyya J; Jain M; Tyagi S; Kumar R; Pati HP; Saxena R
    Indian J Pathol Microbiol; 2007 Jul; 50(3):652-4. PubMed ID: 17883173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells.
    Wang J; Saunthararajah Y; Redner RL; Liu JM
    Cancer Res; 1999 Jun; 59(12):2766-9. PubMed ID: 10383127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the oligomerization domain of ETO interferes with RUNX1/ETO oncogenic activity in t(8;21)-positive leukemic cells.
    Wichmann C; Chen L; Heinrich M; Baus D; Pfitzner E; Zörnig M; Ottmann OG; Grez M
    Cancer Res; 2007 Mar; 67(5):2280-9. PubMed ID: 17332359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations.
    Yuan Y; Zhou L; Miyamoto T; Iwasaki H; Harakawa N; Hetherington CJ; Burel SA; Lagasse E; Weissman IL; Akashi K; Zhang DE
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10398-403. PubMed ID: 11526243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.